COSCIENS Biopharma Inc. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
COSCIENS Biopharma Inc. (CSCIF) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $17.08 per share as of 2023-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2024-07-17
- 2023-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $17.08.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $27.74.
- 2021-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $1.84.
- 2020-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $2.61.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2023-12-31 | $17.08 20-F/A · filed 2024-07-17 |
| 2022-12-31 | $27.74 20-F/A · filed 2024-02-15 |
| 2021-12-31 | $1.84 20-F · filed 2022-03-29 |
| 2020-12-31 | $2.61 40-F/A · filed 2021-03-29 |
| 2019-12-31 | $4.58 20-F · filed 2020-03-31 |